Revenue growth has oscillated between 1.1% and 11.4% year over year and decelerated to 3.1% in Q3 2026, while gross margin ranged from 64.7% to 72.4% and operating margin from 12.8% to 19.2%, with EPS swinging between $0.70 and $1.23 more sharply than revenue, which may indicate significant non-operating or tax-related influences.
Zimmer Biomet Holdings, Inc. (ZBH) annual income statement — 27-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 |
|---|
| Sales/Revenue | 8.57B | 8.23B | 7.68B | 7.39B | 6.94B | 6.83B | 6.13B | 7.98B | 7.93B | 7.8B | 7.67B | 6B | 4.67B | 4.62B | 4.47B | 4.45B | 4.22B | 4.1B | 4.12B | 3.9B | 3.5B | 3.29B | 2.98B | 1.9B | 1.37B | 1.18B | 1.04B | 939M |
| Revenue Growth % | 6.98% | 7.2% | 3.85% | 6.55% | 1.65% | 11.42% | -23.24% | 0.62% | 1.66% | 1.76% | 27.85% | 28.34% | 1.08% | 3.39% | 0.45% | 5.49% | 3.05% | -0.62% | 5.74% | 11.5% | 6.37% | 10.24% | 56.81% | 38.52% | 16.44% | 13.26% | 10.82% | - |
| Cost of Goods Sold | 2.6B | 3.16B | 2.19B | 2.08B | 2.02B | 1.96B | 1.82B | 2.25B | 2.27B | 2.13B | 2.38B | 1.8B | 1.24B | 1.29B | 1.13B | 1.12B | 1.01B | 990.7M | 997.3M | 875.9M | 780.1M | 739.4M | 779.9M | 516.2M | 344.8M | 325.9M | 290.9M | 269M |
| COGS % of Revenue | - | 38.38% | 28.54% | 28.18% | 29.1% | 28.71% | 29.77% | 28.22% | 28.64% | 27.33% | 31.06% | 30.02% | 26.59% | 27.82% | 25.16% | 25.2% | 23.98% | 24.19% | 24.2% | 22.47% | 22.32% | 22.5% | 26.16% | 27.15% | 25.12% | 27.65% | 27.96% | 28.65% |
| Gross Profit | 5.97B | 5.07B | 5.49B | 5.31B | 4.92B | 4.87B | 4.3B | 5.73B | 5.66B | 5.67B | 5.29B | 4.2B | 3.43B | 3.34B | 3.35B | 3.33B | 3.21B | 3.1B | 3.12B | 3.02B | 2.72B | 2.55B | 2.2B | 1.38B | 1.03B | 852.7M | 749.7M | 670M |
| Gross Margin % | 69.68% | 61.62% | 71.46% | 71.82% | 70.9% | 71.29% | 70.23% | 71.78% | 71.36% | 72.67% | 68.94% | 69.98% | 73.41% | 72.18% | 74.84% | 74.8% | 76.02% | 75.81% | 75.8% | 77.53% | 77.68% | 77.5% | 73.84% | 72.85% | 74.88% | 72.35% | 72.05% | 71.35% |
| Gross Profit Growth % | - | -7.57% | 3.33% | 7.93% | 1.1% | 13.1% | -24.9% | 1.21% | -0.17% | 7.26% | 25.96% | 22.35% | 2.79% | -0.27% | 0.5% | 3.8% | 3.33% | -0.61% | 3.38% | 11.28% | 6.62% | 15.71% | 58.94% | 34.76% | 20.51% | 13.74% | 11.9% | - |
| Operating Expenses | 4.68B | 3.71B | 4.2B | 4.03B | 4.22B | 4.01B | 4.22B | 4.59B | 5.63B | 4.87B | 4.47B | 3.73B | 2.39B | 2.04B | 2.3B | 2.31B | 2.29B | 2.09B | 2.03B | 1.89B | 1.55B | 1.49B | 1.44B | 934.1M | 626.7M | 604.4M | 481.7M | 439M |
| OpEx % of Revenue | - | 45.07% | 54.72% | 54.54% | 60.87% | 58.68% | 68.87% | 57.53% | 70.94% | 62.42% | 58.23% | 62.19% | 51.21% | 44.08% | 51.41% | 51.79% | 54.29% | 50.93% | 49.35% | 48.6% | 44.35% | 45.39% | 48.23% | 49.14% | 45.66% | 51.28% | 46.29% | 46.75% |
| Selling, General & Admin | 3.47B | 3.25B | 2.93B | 2.84B | 2.76B | 2.84B | 2.71B | 3.34B | 3.38B | 3.1B | 2.94B | 2.66B | 1.98B | 1.83B | 1.91B | 1.86B | 1.77B | 1.76B | 1.77B | 1.49B | 1.36B | 1.26B | 1.19B | 737.5M | 546M | 532.8M | 429.7M | 394M |
| SG&A % of Revenue | - | 39.5% | 38.16% | 38.39% | 39.79% | 41.65% | 44.27% | 41.89% | 42.6% | 39.79% | 38.4% | 44.36% | 42.33% | 39.66% | 42.76% | 41.86% | 41.85% | 43.07% | 43.02% | 38.22% | 38.79% | 38.33% | 39.92% | 38.8% | 39.78% | 45.21% | 41.29% | 41.96% |
| Research & Development | 432.9M | 458.5M | 437.4M | 458.7M | 406M | 435.8M | 322.8M | 449.3M | 391.7M | 369.9M | 365.6M | 268.8M | 191.9M | 204.2M | 225.6M | 238.4M | 218.5M | 205.7M | 192.3M | 209.6M | 188.3M | 175.5M | 166.7M | 105.8M | 80.7M | 71.6M | 52M | 45M |
| R&D % of Revenue | - | 5.57% | 5.7% | 6.2% | 5.85% | 6.38% | 5.27% | 5.63% | 4.94% | 4.74% | 4.77% | 4.48% | 4.11% | 4.42% | 5.05% | 5.36% | 5.18% | 5.02% | 4.67% | 5.38% | 5.39% | 5.34% | 5.59% | 5.57% | 5.88% | 6.08% | 5% | 4.79% |
| Other Operating Expenses | 4M | 0 | 834.5M | 735.1M | 1.06B | 727.4M | 1.18B | 799M | 1.86B | 1.4B | 1.16B | 800.6M | 223.1M | 6M | 161.2M | 203.8M | 306.8M | 116.2M | 68.5M | 194.7M | 6.1M | 56.6M | 81.1M | 90.8M | 0 | 0 | 0 | 0 |
| Operating Income | 1.29B | 1.36B | 1.29B | 1.28B | 696.3M | 860.3M | 83.1M | 1.14B | 33.8M | 799.3M | 821.1M | 467.3M | 1.04B | 1.04B | 1.05B | 1.02B | 916.7M | 1.02B | 1.09B | 1.13B | 1.17B | 1.05B | 763.2M | 450.7M | 400.9M | 248.3M | 268M | 231M |
| Operating Margin % | 15.11% | 16.55% | 16.74% | 17.28% | 10.03% | 12.6% | 1.36% | 14.25% | 0.43% | 10.24% | 10.71% | 7.79% | 22.2% | 22.4% | 23.42% | 23% | 21.72% | 24.88% | 26.45% | 28.93% | 33.34% | 32.1% | 25.6% | 23.71% | 29.21% | 21.07% | 25.75% | 24.6% |
| Operating Income Growth % | - | 5.95% | 0.63% | 83.5% | -19.06% | 935.26% | -92.69% | 3265.38% | -95.77% | -2.66% | 75.71% | -54.95% | 0.16% | -1.13% | 2.28% | 11.72% | -10.02% | -6.53% | -3.33% | -3.23% | 10.45% | 38.23% | 69.34% | 12.42% | 61.46% | -7.35% | 16.02% | - |
| EBITDA | 2.4B | 2.46B | 2.28B | 2.23B | 1.62B | 1.8B | 981.5M | 2.14B | 1.07B | 1.86B | 1.86B | 1.18B | 1.41B | 1.39B | 1.41B | 1.38B | 1.26B | 1.36B | 1.37B | 1.36B | 1.36B | 1.24B | 944.5M | 554M | 426.2M | 271.7M | 291.1M | 253M |
| EBITDA Margin % | 28.02% | 29.84% | 29.72% | 30.15% | 23.38% | 26.34% | 16.02% | 26.85% | 13.54% | 23.86% | 24.26% | 19.67% | 30.24% | 30.15% | 31.54% | 31.09% | 29.78% | 33.12% | 33.12% | 34.83% | 38.98% | 37.76% | 31.69% | 29.14% | 31.06% | 23.05% | 27.97% | 26.94% |
| EBITDA Growth % | -0.19% | 7.62% | 2.36% | 37.39% | -9.75% | 83.19% | -54.21% | 99.53% | -42.3% | 0.09% | 57.7% | -16.52% | 1.36% | -1.16% | 1.91% | 10.11% | -7.32% | -0.65% | 0.55% | -0.37% | 9.83% | 31.36% | 70.49% | 29.99% | 56.86% | -6.66% | 15.06% | - |
| D&A (Non-Cash Add-back) | 1.11B | 1.09B | 996.3M | 951.7M | 926.4M | 937.7M | 898.4M | 1.01B | 1.04B | 1.06B | 1.04B | 712.4M | 375.8M | 358.5M | 363.1M | 359.9M | 340.2M | 337.4M | 275.1M | 230M | 197.4M | 185.7M | 181.3M | 103.3M | 25.3M | 23.4M | 23.1M | 22M |
| EBIT | 1.18B | 1.12B | 1.25B | 1.27B | 568.3M | 707.4M | 106.9M | 1.13B | 18.2M | 789.9M | 754.6M | 439.8M | 1B | 1.05B | 1.06B | 1.03B | 920.4M | 1.14B | 1.16B | 1.15B | 1.17B | 1.11B | 844.3M | 541.5M | 400.9M | 248.3M | 268M | 231M |
| Net Interest Income | -288.5M | -292.8M | -218M | -201.2M | -164.8M | -208.4M | -212.1M | -226.9M | -289.3M | -325.3M | -355M | -277.2M | -51.2M | -54.5M | -57.3M | -45.2M | -56.5M | -20.6M | 31.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.4M | 11.9M | 15.6M | 15.6M | 10.1M | 3.7M | 0 | 31.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 288.5M | 292.8M | 218M | 201.2M | 164.8M | 208.4M | 212.1M | 226.9M | 289.3M | 325.3M | 355M | 286.6M | 63.1M | 70.1M | 72.9M | 55.3M | 60.2M | 20.6M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -410.2M | -531.4M | -249.1M | -210.4M | -292.8M | -361.3M | -188.3M | -231.7M | -304.9M | -334.7M | -421.5M | -314.1M | -97.9M | -87.5M | -57.3M | -45.2M | -56.5M | -20.6M | 31.8M | 4M | 3.8M | -14.3M | -31.7M | -13.2M | -12M | -7.4M | 0 | 0 |
| Pretax Income | 884.5M | 830.8M | 1.04B | 1.07B | 403.5M | 499M | -105.2M | 905.8M | -271.1M | 464.6M | 399.6M | 153.2M | 939.4M | 981.1M | 990.1M | 978.9M | 860.2M | 998.2M | 1.12B | 1.13B | 1.17B | 1.04B | 731.5M | 437.5M | 388.9M | 240.9M | 268M | 231M |
| Pretax Margin % | 10.32% | 10.09% | 13.5% | 14.43% | 5.81% | 7.31% | -1.72% | 11.35% | -3.42% | 5.95% | 5.21% | 2.55% | 20.1% | 21.22% | 22.14% | 21.99% | 20.38% | 24.37% | 27.22% | 29.03% | 33.44% | 31.67% | 24.54% | 23.01% | 28.34% | 20.44% | 25.75% | 24.6% |
| Income Tax | 115.8M | 125.7M | 131.4M | 42.2M | 112.3M | 53.5M | -96M | -225.7M | 108.2M | -1.35B | 95M | 7M | 220.2M | 221.9M | 237.2M | 218.9M | 263.3M | 280.8M | 272.3M | 357.9M | 334M | 307.3M | 189.6M | 146.8M | 131.1M | 91.1M | 92M | 81M |
| Effective Tax Rate % | 13.09% | 15.13% | 12.68% | 3.95% | 27.83% | 10.72% | 91.25% | -24.92% | -39.91% | -290.31% | 23.77% | 4.57% | 23.44% | 22.62% | 23.96% | 22.36% | 30.61% | 28.13% | 24.27% | 31.63% | 28.57% | 29.53% | 25.92% | 33.55% | 33.71% | 37.82% | 34.33% | 35.06% |
| Net Income | 767.5M | 705.2M | 903.8M | 1.02B | 231.4M | 401.6M | -138.9M | 1.13B | -379.2M | 1.81B | 305.9M | 147M | 720.3M | 761M | 755M | 760.8M | 596.9M | 717.4M | 848.6M | 773.2M | 834.5M | 732.5M | 541.8M | 346.3M | 257.8M | 149.8M | 176M | 150M |
| Net Margin % | 8.96% | 8.57% | 11.77% | 13.85% | 3.33% | 5.88% | -2.27% | 14.18% | -4.78% | 23.24% | 3.99% | 2.45% | 15.41% | 16.46% | 16.88% | 17.09% | 14.14% | 17.52% | 20.59% | 19.84% | 23.87% | 22.29% | 18.18% | 18.22% | 18.78% | 12.71% | 16.91% | 15.97% |
| Net Income Growth % | -4.68% | -21.97% | -11.74% | 342.52% | -42.38% | 389.13% | -112.27% | 398.42% | -120.91% | 492.94% | 108.1% | -79.59% | -5.35% | 0.79% | -0.76% | 27.46% | -16.8% | -15.46% | 9.75% | -7.35% | 13.92% | 35.2% | 56.45% | 34.33% | 72.1% | -14.89% | 17.33% | - |
| Net Income (Continuing) | 768.7M | 705.1M | 905.2M | 1.03B | 291.2M | 445.5M | -9.2M | 1.13B | -379.3M | 1.81B | 304.6M | 146.2M | 719M | 759.2M | 752.9M | 760M | 596.9M | 717.4M | 849.5M | 773.2M | 834.5M | 732.5M | 541.8M | 291.2M | 257.8M | 149.8M | 176M | 150M |
| Discontinued Operations | 0 | 0 | 0 | 0 | -58.8M | -43.4M | -128.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 10M | 8.1M | 8.1M | 7.7M | 6.7M | 5.7M | 5.2M | 4.7M | 4.8M | -300K | 1M | 1.5M | 1.8M | 2.8M | 5.4M | 7.6M | 0 | 0 | 3.6M | 2.8M | 2.7M | 2.3M | 7.1M | 7M | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 4.01 | 3.55 | 4.43 | 4.88 | 1.10 | 1.85 | -0.65 | 5.31 | -1.81 | 8.77 | 1.46 | 0.26 | 4.19 | 4.43 | 4.29 | 4.03 | 2.97 | 3.32 | 3.72 | 3.26 | 3.40 | 2.93 | 2.19 | 1.64 | 1.31 | 0.77 | 0.91 | 0.77 |
| EPS Growth % | -2.23% | -19.86% | -9.22% | 343.64% | -40.68% | 385.07% | -112.25% | 394.09% | -120.6% | 502% | 460.12% | -93.79% | -5.42% | 3.26% | 6.45% | 35.69% | -10.54% | -10.75% | 14.11% | -4.12% | 16.04% | 33.79% | 33.54% | 25.19% | 70.13% | -15.38% | 18.18% | - |
| EPS (Basic) | - | 3.56 | 4.45 | 4.91 | 1.10 | 1.87 | -0.65 | 5.36 | -1.81 | 8.84 | 1.47 | 0.27 | 4.26 | 4.49 | 4.32 | 4.06 | 2.98 | 3.34 | 3.73 | 3.28 | 3.43 | 2.96 | 2.22 | 1.67 | 1.33 | 0.77 | 0.91 | 0.77 |
| Diluted Shares Outstanding | 191.4M | 198.7M | 203.9M | 209.7M | 210.3M | 216.71M | 213.21M | 212.9M | 209.6M | 209.81M | 208.47M | 189.8M | 171.7M | 171.8M | 176M | 188.7M | 201.1M | 215.8M | 228.3M | 237.5M | 245.4M | 249.8M | 247.8M | 211.2M | 196.8M | 194.3M | 193.6M | 193.6M |
| Basic Shares Outstanding | 190.5M | 198M | 203.1M | 208.7M | 209.6M | 214.86M | 213.21M | 211.25M | 209.6M | 207.96M | 206M | 187.4M | 169M | 169.6M | 174.9M | 187.6M | 200M | 215M | 227.3M | 235.5M | 243M | 247.1M | 244.4M | 207.7M | 194.5M | 193.7M | 193.6M | 193.6M |
| Dividend Payout Ratio | - | 26.99% | 21.69% | 19.62% | 86.95% | 49.83% | - | 17.38% | - | 10.67% | 61.59% | 106.87% | 20.2% | 17.4% | 12.5% | 67.09% | - | - | - | - | - | - | - | - | - | 193.59% | - | - |
Quick answers to the most common questions about buying ZBH stock.
For fiscal year 2025, Zimmer Biomet Holdings, Inc. (ZBH) reported total revenue of $8.23B. This represents a 776.6% increase compared to $939.0M in 1999.
Zimmer Biomet Holdings, Inc. (ZBH) is profitable, generating $705.2M in net income for the fiscal year ending 2025 with a net profit margin of 8.6%.
Zimmer Biomet Holdings, Inc. (ZBH) reported an operating income of $1.36B, resulting in an operating profit margin of 16.5%. This margin reflects the operational efficiency of the business before interest and taxes.
Zimmer Biomet Holdings, Inc. (ZBH) generated $5.07B in gross profit for the year, representing a gross profit margin of 61.6%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
China VBP price erosion
Metrics are mathematically derived from official filings.
Low-Single-Digit Growth Persists Despite Volatility
Based on reported quarterly figures, ZBH's revenue growth has oscillated between 1.1% and 11.4% year over year over the last ten quarters, with the most recent print at 3.1% suggesting a deceleration from the 9.3% reported in the prior cycle.
The quarterly series shows growth clustering in a low-to-mid single-digit band rather than accelerating, which may indicate that volume gains are being offset by price concessions in mature implant lines. The swings appear partly tied to timing effects and the ZimVie separation, so year-over-year comparisons should be treated with caution. Investors should monitor whether the cementless knee mix and ROSA adoption can lift growth durably above this band.
Gross Margin Oscillates Around Seventy Percent
As reported in quarterly financial statements, ZBH's gross margin ranged from 64.7% to 72.4% over the period, with the latest quarter at 71.2%, indicating a structurally high but cyclically variable margin profile.
The gross margin band appears to be relatively stable in the low-70s outside of isolated dips, which is consistent with a franchise supported by specialized implant pricing. The troughs, particularly the 64.7% print, may reflect inventory charges or mix effects rather than a permanent shift, though the data alone cannot confirm the cause. Continued pressure from GPO price concessions and APAC deflation would likely be the primary threat to sustaining these levels.
Operating Margin Shows Limited Scaling
Based on reported figures, ZBH's operating margin has fluctuated between 12.8% and 19.2%, and the latest 14.9% reading suggests operating income is not consistently scaling with gross profit across quarters.
SG&A remains the dominant expense line, running at roughly 40% of revenue, so modest revenue growth translates into limited operating leverage. The inconsistency between gross profit stability and operating margin volatility suggests overhead and commercial spend absorb much of any incremental gross profit. This pattern warrants further investigation into whether the expense base can be structurally reduced.
EPS Volatility Outpaces Revenue Trend
According to reported quarterly data, ZBH's diluted EPS swung between $0.70 and $1.23 over ten quarters, a range far wider than the revenue trend, which may indicate significant non-operating or tax-related influences on reported earnings.
Net margin variability from 6.2% to 13.7% is considerably larger than gross margin variability, implying that below-the-line items such as tax rate changes, interest, or one-time charges materially affect reported profit. Stock-based compensation of roughly $20-26 million per quarter is modest relative to net income and does not appear to explain the swings. The most recent EPS miss relative to consensus, noted in company commentary, further suggests earnings conversion is an area requiring monitoring.
Margin Erosion Risk from Price Deflation
The strongest bear case is that ZBH's Q4 2025 gross margin trough at 64.7% and recurring APAC pricing pressure from China's VBP program may signal structural erosion rather than one-time noise, though this remains an inference from limited quarterly data.
If GPO price concessions and VBP-driven deflation continue to compound, the current low-70s gross margin could drift lower, compressing operating income even if unit volumes grow. Revenue growth that has decelerated to 3.1% in the latest quarter, combined with an EPS decline of 13.8% year over year, would be consistent with this downside scenario. Investors should monitor gross margin trajectory closely, as the thesis depends on mix shift offsetting price erosion.